Blueshift Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

Blueshift Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$122.5 - $147.16 $283,465 - $340,528	2,314 New	2,314 $286,000
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $240,561 - $286,553	-1,699 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$129.64 - $160.7 $8,167 - $10,124	63 Added 3.85%	1,699 $264,000
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $678,104 - $824,055	-5,657 Reduced 77.57%	1,636 $208,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $773,512 - $1.11 Million	6,013 Added 469.77%	7,293 $950,000
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $808,529 - $940,861	-5,047 Reduced 79.77%	1,280 $227,000
Q1 2021 May 06, 2021	BUY	$150.19 - $173.5 $758,309 - $876,001	5,049 Added 395.07%	6,327 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $179,827 - $210,933	1,278 New	1,278 $211,000
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $306,108 - $359,233	-2,513 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$115.94 - $166.74 $291,357 - $419,017	2,513 New	2,513 $312,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.